259 related articles for article (PubMed ID: 639368)
21. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
Arlart IP; Rosenthal J; Wagner H; Franz HE
Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II blockade and the functions of the renin-angiotensin system.
Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin-aldosterone system in arterial hypertension.
Horký K; Gregorová I
Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
[TBL] [Abstract][Full Text] [Related]
25. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
[TBL] [Abstract][Full Text] [Related]
26. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
27. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys.
Linas SL; Miller PD; McDonald KM; Stables DP; Katz F; Weil R; Schrier RW
N Engl J Med; 1978 Jun; 298(26):1440-4. PubMed ID: 349389
[TBL] [Abstract][Full Text] [Related]
28. The adrenal receptor for angiotensin II is altered in essential hypertension.
Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery.
Freeman RH; Davis JO; Watkins BE; Lohmeier TE
Circ Res; 1977 May; 40(5 Suppl 1):I29-35. PubMed ID: 870229
[TBL] [Abstract][Full Text] [Related]
30. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
31. The use of saralasin in the recognition of angiotensinogenic hypertension.
Streeten DH; Dalakos TG; Anderson GH
Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
[TBL] [Abstract][Full Text] [Related]
32. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
33. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
[TBL] [Abstract][Full Text] [Related]
34. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
[TBL] [Abstract][Full Text] [Related]
35. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
36. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
Vierhapper H; Waldhäusl W
Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
[TBL] [Abstract][Full Text] [Related]
37. Effect of blockade of angiotensin II on blood pressure, renin and aldosterone in cirrhosis.
Schroeder ET; Anderson GH; Goldman SH; Streeten DH
Kidney Int; 1976 Jun; 9(6):511-9. PubMed ID: 940284
[TBL] [Abstract][Full Text] [Related]
38. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)].
Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M
G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235
[TBL] [Abstract][Full Text] [Related]
39. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
[No Abstract] [Full Text] [Related]
40. Effects of 1-sar-8-ala-angiotensin II on arterial pressure, renin and aldosterone in hypertension.
Fagard R; Lijnen P; Amery A; Reybrouck T
Contrib Nephrol; 1978; 11():175-8. PubMed ID: 699588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
